サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541310

HPV検査とPAP検査の市場レポート：検査タイプ、製品、用途、エンドユーザー、地域別、2024～2032年

HPV Testing and PAP Test Market Report by Test Type, Product, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 147 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HPV検査とPAP検査の市場レポート：検査タイプ、製品、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のHPV検査とPAP検査の市場規模は2023年に42億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに67億米ドルに達し、2024～2032年の成長率（CAGR）は5.2％になると予測しています。

ヒトパピローマウイルス（HPV）は、子宮頸部、口腔咽頭、陰茎、外陰部のがんを引き起こす性感染症（STI）です。HPVやパパニコロウ（PAP）検査など、様々な検査や処置によって検出することができます。これらの検査は、検体の顕微鏡観察と子宮頸がん、頭頸部がんのスクリーニングからなります。このうち、HPV検査は性器疣贅の発生に先立つヒトパピローマウイルスの存在を評価するために、PAP検査は子宮頸部における細胞の変化や異常細胞の存在を判定するために用いられます。

HPV検査とPAP検査の市場動向

パピローマウイルスの存在により、特に成人層で子宮頸がんの有病率が増加していることが、新しい、技術的に進んだ、費用対効果の高いHPVとPAPスクリーニングの必要性を促進しており、これが主に市場成長を促進する主要要因の1つとなっています。これに伴い、HPV感染がんの早期段階での検出と治療反応のモニタリングのための、機械支援による血漿と無細胞のデオキシリボ核酸（DNA）スクリーニングの採用が、もう一つの成長促進要因として作用しています。これはさらに、コロナウイルス感染症（COVID-19）の突然の大流行を理由に、使いやすい家庭用HPVスクリーニング検査など、主要参入企業による継続的な臨床検査、開発、製品の発売が、市場における競争優位性をもたらしていることも後押ししています。医療セグメントの急速な拡大や、子宮頸がんの原因やHPV検査とPAP検査を受けることの利点について人々に注意を喚起するために政府機関や非政府組織（NGO）が行っている数多くの好意的な取り組みなどのその他の要因が、市場に明るい展望を生み出しています。

本レポートで扱う主要質問

  • HPV検査とPAP検査の市場の世界市場規模は？
  • 2024～2032年における世界のHPV検査とPAP検査の市場の予想成長率は？
  • 世界のHPV検査とPAP検査の市場を牽引する主要因は何か？
  • 世界のHPV検査とPAP検査の市場に対するCOVID-19の影響は？
  • HPV検査とPAP検査の市場の世界における検査タイプ別の内訳は？
  • 世界のHPV検査とPAP検査の市場の製品別内訳は？
  • 世界のHPV検査とPAP検査の市場の用途別の内訳は？
  • 世界のHPV検査とPAP検査の市場のエンドユーザー別内訳は？
  • HPV検査とPAP検査の市場の世界における主要地域は？
  • 世界のHPV検査とPAP検査の市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のHPV検査とPAP検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：検査タイプ別

  • HPV検査
  • PAP検査
  • 共同検査

第7章 市場内訳：製品別

  • 機器
  • 消耗品
  • サービス

第8章 市場内訳：用途別

  • 子宮頸がん検診
  • 膣がん検診

第9章 市場内訳：エンドユーザー別

  • 病院とクリニック
  • 研究所
  • 診断センター
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Arbor Vita Corporation
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Biocon Limited
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • NURX Inc.（Thirty Madison Inc.）
    • Qiagen N.V.
    • Quest Diagnostics Incorporated
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2023
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2023
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2023
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2023
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players
目次
Product Code: SR112024A5889

The global HPV testing and PAP test market size reached US$ 4.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices.

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

HPV Test

Pap Test

Co-testing

Breakup by Product:

Instruments

Consumables

Services

Breakup by Application:

Cervical Cancer Screening

Vaginal Cancer Screening

Breakup by End User:

Hospitals and Clinics

Laboratories

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global HPV testing and PAP test market?
  • 2. What is the expected growth rate of the global HPV testing and PAP test market during 2024-2032?
  • 3. What are the key factors driving the global HPV testing and PAP test market?
  • 4. What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • 5. What is the breakup of the global HPV testing and PAP test market based on the test type?
  • 6. What is the breakup of the global HPV testing and PAP test market based on the product?
  • 7. What is the breakup of the global HPV testing and PAP test market based on the application?
  • 8. What is the breakup of the global HPV testing and PAP test market based on the end user?
  • 9. What are the key regions in the global HPV testing and PAP test market?
  • 10. Who are the key players/companies in the global HPV testing and PAP test market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global HPV Testing and PAP Test Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14 Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis